Anesthesia Care, Complications, and Airway Management for Patients With Spinal Muscular Atrophy: A Retrospective Chart Review From a Quaternary Children’s Hospital

Anesth AnalgPublished Retrospective chart review

Authors' conclusion

Lumbar puncture for nusinersen administration made up the vast majority of procedures for which patients with SMA presented for anesthesia care. The incidence of difficult intubation was 9.4%, and the incidence of anesthesia-related severe adverse events was 0.33%.

Study context

Population
Patients with spinal muscular atrophy (SMA) receiving anesthetics at a quaternary pediatric hospital, June 1, 2012, to December 30, 2023
Participants
175 patients · 1,804 procedures
Outcome
Incidence of severe anesthesia-related adverse events and of difficult intubations; procedures performed
Methodological detailssingle-centre, quaternary children's hospital
  • Single-centre
  • Quaternary children's hospital

Main finding

As reported in the abstract

Procedures for LP for nusinersen administration
1423/1804, 78.9%
GA with ETT placement
234 of 1804 (13.0%)
Difficult intubation, of all cases
22 of 1804 total cases (1.2%)
Difficult intubation, of ETT placements
22 of 234 (9.4%)
Severe anesthesia-related adverse events
six (0.33%)

Observational data: associations, not effects.

Further findings

Difficult intubation vs SMA type, age, halo headframe

No statistically significant associations
all P > .05

Airway for LP for nusinersen administration

Natural airway (nasal canula, facemask, or home CPAP or BiPAP) or pre-existing tracheostomy
1254 of 1423 (88.1%)

Safety

Severe anesthesia-related adverse events
six (0.33%)

Original publication

Anesthesia Care, Complications, and Airway Management for Patients With Spinal Muscular Atrophy: A Retrospective Chart Review From a Quaternary Children’s Hospital. Anesth Analg. Published 25 June 2026. doi:10.1213/ane.0000000000008155

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.